A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Clinical trial NCT04923139 · COMPLETED

Trial details

NCT number: NCT04923139
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Treatment of Venous Thromboembolism

Start date: 2022-01-24
Primary completion: 2022-12-31
Enrollment: 2627

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.